Sanaregen Vision Therapeutics initiates crowdfunding and invites prospective investors to reserve stock on StartEngine
Potential investment is intended to support Sanaregen’s clinical trials targeting Macular Degeneration and Geographic Atrophy NASHVILLE, TN, UNITED STATES, June 26, 2025 /EINPresswire.com/ -- Sanaregen Vision Therapeutics, a clinical stage …